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Abstract
Cell morphogenesis, which requires rearrangement of the actin cytoskeleton, is essential to coordinate the development of
tissues such as the musculature and nervous system during normal embryonic development. One class of signaling proteins
that regulate actin cytoskeletal rearrangement is the evolutionarily conserved CDM (C. elegans Ced-5, human DOCK180,
Drosophila Myoblast city, or Mbc) family of proteins, which function as unconventional guanine nucleotide exchange factors
for the small GTPase Rac. This CDM-Rac protein complex is sufficient for Rac activation, but is enhanced upon the
association of CDM proteins with the ELMO/Ced-12 family of proteins. We identified and characterized the role of Drosophila
Sponge (Spg), the vertebrate DOCK3/DOCK4 counterpart as an ELMO-interacting protein. Our analysis shows Spg mRNA
and protein is expressed in the visceral musculature and developing nervous system, suggesting a role for Spg in later
embryogenesis. As maternal null mutants of spg die early in development, we utilized genetic interaction analysis to
uncover the role of Spg in central nervous system (CNS) development. Consistent with its role in ELMO-dependent
pathways, we found genetic interactions with spg and elmo mutants exhibited aberrant axonal defects. In addition, our data
suggests Ncad may be responsible for recruiting Spg to the membrane, possibly in CNS development. Our findings not only
characterize the role of a new DOCK family member, but help to further understand the role of signaling downstream of N-
cadherin in neuronal development.
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Introduction
The formation of embryonic tissues is a key feature in
generating diversity in animal development. After cell fate is
established, cell-cell signaling and intracellular signal transduction
pathways instruct cells to undergo cell shape changes. These cell
shape changes are necessary for cell movement, a basic process
that underlies embryonic development and is largely accomplished
by regulation of the actin cytoskeleton. Actin dynamics is required
for the migration of individual groups of cells, as in border cell
migration in the Drosophila ovary, or large groups of cells, such as
those involved in gastrulation in the developing fly embryo [1,2].
One common feature of cell rearrangements via the actin
cytoskeleton is the involvement of the Rho family of GTPases
[3,4].
Widely conserved across species and involved in seemingly
diverse developmental processes including cell migration, phago-
cytosis, and myoblast fusion, the Rho GTPases are key signaling
molecules that impinge upon actin cytoskeletal reorganization [5].
Several classes of GTPase regulatory proteins have been identified,
including the GTPase-activating proteins (GAPs), guanine nucle-
otide exchange factors (GEFs), and guanine nucleotide dissociation
inhibitors (GDIs) [6,7]. In particular, the GEFs regulate GTPase
activity by exchanging the inactive, GDP-bound Rac to the
active, GTP-bound state. It is thought that GEFs are a crucial
intermediate that signal from upstream cell surface receptors to
mediate GTPase activation. Some GEFs directly associate with
membrane receptors, while others are associated via an interme-
diate complex. In flies, two neuronally expressed Rac GEFs have
been identified that exemplify this in development of the central
nervous system. Trio physically interacts with the Netrin receptor
Frazzled to regulate chemoattraction [8,9], while Son of sevenless
(Sos) associates with the Roundabout (Robo) receptor through the
SH2-SH3 adaptor protein Dreadlocks (DOCK) to control axon
repulsion [9].
Recent studies have identified a class of non-canonical GEFS
that are members of the CDM (C. elegans Ced-5, human
DOCK180, Drosophila Myoblast city) family of proteins [5,10].
Evolutionarily conserved, Mbc/DOCK180/Ced-5 proteins con-
tain an N-terminal Src-homology-3 domain (SH3), two internal
DOCK-homology regions (DHR-1 and DHR-2), and a C-
terminal proline–rich region. The DHR1 regions of both
DOCK180 and Mbc bind to phosphatidylinositol 3,4,5-triphos-
phate [PtdIns(3,4,5)P3] [11,12]. Vertebrate cell culture studies
show this region is required for membrane localization [12]. In
flies, the DHR1 domain is not essential for recruitment to the
membrane, but is essential for myoblast fusion as deletion of the
DHR1 domain fails to rescue mbc mutant embryos in functional
rescue assays [11]. Although the SH3-domain containing protein
Crk is capable of binding the C-terminal proline-rich region of
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interaction between vertebrate DOCK180 and CrkII is not
required for apoptotic cell removal [13]. Furthermore, deletion of
the Ced-2/Crk binding sites in C. elegans Ced-5/DOCK180 does
not affect cell engulfment or migration [13]. Consistent with this,
while Drosophila Crk binds Mbc, it is dispensable for myoblast
fusion [11]. Whereas canonical GEFs contain both typical Dbl-
homology domain (DH) and Pleckstrin-homology domains (PH)
that are involved in activation of the Rho GTPases, these domains
are absent in CDM family members [10,12]. Conventional GEFs
bind nucleotide-free Rac via their DH domain, while the CDM
proteins use the DHR2 region. Deletion or mutation of this
domain results in a loss of Rac binding and activation [14,15]. A
DOCK-Rac protein complex is sufficient for Rac activation
[12,16], but may be enhanced by DOCK180 bound to ELMO
[14,17,18].
ELMO/Ced-12 (hereafter referred to as ELMO) was originally
identified in C. elegans as an upstream regulator of Rac in apoptotic
cell engulfment and cell migration [19,20,21]. Studies using
mammalian ELMO1 subsequently showed that the DOCK180-
ELMO complex is required for Rac-mediated cell migration and
phagocytosis [14,17,18,22,23]. The PH domain, which in
conventional GEFs targets protein to the membrane through its
interactions with phosphatidylinositol lipids or other protein-
protein interactions, is provided by the ELMO protein in the
DOCK-ELMO complex [14,16]. The N-terminal SH3 domain of
CDM family members associates with the C-terminal region of the
ELMO family of proteins [24]. While the molecular function of
ELMO in the DOCKRRac signaling pathway still needs to be
clarified, it is worth noting that ELMO has functions independent
of the DOCK proteins.
Importantly, studies in Drosophila have provided additional
insight into role of the Mbc-ELMORRac signaling pathway in
multiple tissues. Mutations in mbc and elmo result in border cell
migration defects in the ovary and myoblast fusion defects in the
embryo [25,26,27]. Decreased Mbc and ELMO function exhibit
abnormal ommatididal organization in the eye and thorax closure
defects in the adult [27,28]. In addition, loss-of-function studies
have demonstrated that the Rac genes are required redundantly in
a variety of developmental processes, including border cell
migration, myoblast fusion, and axon guidance in the developing
nervous system [27,29,30,31]. Last, genetic interactions exist
between the atypical GEF Mbc-ELMO complex and their target
GTPase Rac. A genetic screen in the eye uncovered an allele of
mbc that suppresses the Rac1 overexpression phenotype [32]. In
support of this, removal of one copy of both Rac1 and Rac2 are
capable of ameliorating the ‘‘activated-Rac’’ phenotype exhibited
by co-expression of both Mbc and ELMO in the eye [27].
Although the work cited above provides convincing evidence
that the DOCK180/Mbc-ELMO complex is essential in devel-
opment, the mechanism by which at least five Rac-specific DOCK
proteins bind to one or more ELMO proteins in vertebrates to
modulate actin regulation in a tissue-specific manner is not clear.
DOCK180, DOCK4, and DOCK5 are broadly expressed in
many tissues, including the brain and nervous system [33]. In
contrast, DOCK2 is expressed specifically in hematopoietic cells,
while DOCK3 expression is primarily restricted to the brain and
spinal cord [34,35,36]. In addition to their complex expression
patterns, DOCK family members exhibit pleiotropic functions in
development. DOCK180 has recently been shown to be required
for Rac-mediated axon outgrowth in cortical neurons in response
to netrin-1, neurite outgrowth as mediated by nerve growth factor,
and axon pruning via ephrin-B3 [17,37,38]. Mouse knock-outs
show DOCK180 is required in concert with DOCK5 in muscle
fusion [39]. DOCK3 (or modifier of cell adhesion, MOCA)
colocalizes with N-cadherin and actin in neuronal differentiation
[36,40]. MOCA is also linked to Alzheimer’s disease (AD), where
it accumulates in neurofibrillary tangles and modulates beta-
amyloid (APP) precursor processing [41,42,43]. Consistent with
this, mice lacking DOCK3 exhibit axonal degeneration [44].
Finally, knockdown of DOCK4 results in reduced dendritic
growth and branching in hippocampal neurons [45]. Drosophila
provides an excellent system to characterize this conserved
pathway with a single ELMO ortholog. Using proteomics
approaches for identifying new players in the ELMO-mediated
pathway in the developing embryo, we have uncovered Spg, the
Drosophila ortholog of human DOCK3/4, as an ELMO-interacting
protein. In contrast to the well-established role of Mbc in myoblast
fusion, Spg is not required with ELMO in somatic muscle
development. However, the two Drosophila DOCK family
members Mbc and Spg are required in the developing nerve
cord. Moreover, Spg can be recruited to the membrane by N-
cadherin in S2 cells, providing a mechanism for Spg localization
that may function to mediate the development of axonal pathways.
Results
Identification of the DOCK3 and DOCK4 ortholog
CG31048/Sponge as an ELMO-interacting protein
To identify proteins that may interact with ELMO in the
developing embryonic musculature, tissue-specific immunoprecip-
itations (IPs) were carried out as described in Geisbrecht, et al [27].
In brief, either HA-tagged or untagged ELMO, both of which
rescue elmo mutants, were expressed using the muscle-specific mef2-
GAL4 driver. ELMO-specific complexes were isolated from
embryonic lysates with anti-HA resin, digested with trypsin, and
analyzed by Multidimensional Protein Identification Technology
(MudPIT) mass spectrometry [46]. In an average of 5 independent
experiments, the percent peptide coverage of ELMO ranged from
43–73% (Figure 1A), while the most abundant associated protein
was Mbc [27]. Peptides corresponding to the protein CG31048
were detected in lysates immunoprecipitated with tagged ELMO,
but not untagged ELMO. After Mbc, CG31048 was the second
most abundant protein detected, where the percentage of peptide
coverage that corresponded to CG30148 ranged from 2–30%.
While the CG31048 cDNA had not yet been cloned, an abstract
from the 2005 fly meeting by Eyal Schejter, et al., linked this locus
to a maternal effect mutant called sponge (spg), whose name we will
use hereafter. An allele of spg was originally identified by Rice and
Garen [47], while more alleles emerged from screens in the
laboratory of C. Nusslein-Volhard. Postner, et al., examined the
role of Spg in early actin cap and metaphase furrow formation in
early embryonic development [48]. In addition, the Rorth lab
determined that both Mbc and Spg function redundantly in
border cell migration downstream of the receptor PVR [49].
However, the role of Spg in later embryonic processes has not
been examined.
Spg is most closely related to both mammalian DOCK3/
MOCA and DOCK4 and is a CDM family member whose
domain structure is highly similar to Mbc (Figure 1B). All of these
related proteins contain an N-terminal Src-homology 3 domain
(SH3), and internal DOCK homology region-1 (DHR-1) and
DOCK homology region-2 (DHR-2) domains. Spg shares greater
amino acid sequence identity to vertebrate DOCK3 and DOCK 4
(42% and 40%, respectively) than Mbc (33%). This primary amino
acid identity/similarity (33%/52%) between Spg and Mbc
decreases to 16% amino acid identity and 21% amino acid in
the C-terminal proline-rich region. Notably, the C-terminal region
DOCK Family Members in Drosophila CNS Development
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This is similar to vertebrate analyses of DOCK family members,
where the number of proline-rich sites in the C-terminal region of
DOCK3 and DOCK4 is greater than that found in DOCK180
alone [50]. It is hypothesized that this region may confer
differential properties of DOCK family function.
To confirm a potential physical interaction between ELMO and
CG31048, we generated antisera to the C-terminal region of Spg
that is the most divergent from Mbc. Similar to the MS
experiments in which Spg was identified, both HA-tagged ELMO
and untagged ELMO were expressed in the developing muscu-
lature with mef2-GAL4. After preparing embryonic lysates, anti-HA
beads were used to immunoprecipitate HA-tagged and untagged
ELMO. Consistent with results that show both vertebrate
DOCK3 and DOCK4 are associated with ELMO [23,51], Spg
could be visualized in an ELMO-associated complex by
immunoblotting with anti-Spg (Figure 1C).
Spg mRNA and protein is strongly expressed in the
developing nervous system
Portions of the spg transcript were identified in a screen for
neural precursor genes [52]. We confirmed this using in situ
hybridization analysis that revealed spg mRNA is expressed strongly
in the developing nervous system throughout embryonic develop-
ment. In situs showed spg mRNA is detected in the nervous system
primordia and sensory neurons in stage 11 and stage 13 embryos
(Figure 2A, B). This strong expression persisted in the ventral
nerve cord until the end of embryogenesis (Figure 2E, F). Staining
in the visceral mesoderm in stage 13 embryos (Figure 2C,
arrowheads) confirmed the identification of Spg from our muscle-
specific MS analysis as the mef2-GAL4 driver is expressed in both
the visceral and somatic musculature. Similar to mbc [26], spg
mRNA expression was also apparent in the dorsal vessel (Figure 2D,
E, arrows). While mbc is also expressed abundantly in the
developing somatic, or body wall musculature [26], spg expression
is low or undetectable in this tissue (Figure 2C, solid lines). Thus,
spg and mbc exhibit overlapping RNA expression patterns in the
developing visceral musculature and dorsal vessel [26], while they
are uniquely expressed in others. Mbc is strong in the somatic
musculature, while Spg expression is predominant in the
developing nervous system.
To confirm and extend our mRNA expression analysis, we
examined the distribution of Spg protein using antisera generated
against the C-terminal region of Spg. Consistent with spg mRNA
expression, Spg protein was detected in the ventral nerve cord and
visceral mesoderm (Figure 2G, H). A ventral view also revealed
expression in the peripheral neurons (Figure 2I, arrows). In
addition, Spg immunoreactivity was apparent in all longitudinal
and commissural neurons (Figures 2J-J0). Spg was not detected in
the general population of glial cells by co-staining with the glial cell
marker Repo at stage 13 (Figure 2K-K0) or the midline glial cell
marker Slit at stage 16 (Figure 2L-L0).
Spg and ELMO are required for development of the
central nervous system
All alleles of spg isolated in the laboratory of Christian Nu ¨sslein-
Volhard and analyzed by the Weischaus lab were homozygous
viable and female sterile [48]. Although many of the original
alleles were not available for these studies, a stop codon was
identified by sequencing the spg
242 (previously called spg
2) allele
(W487*). Consistent with Postner, et al. [48], we found that eggs
produced from spg
242 homozygous mothers with a mutant paternal
Figure 1. Identification of CG31048/Spg as an ELMO-binding protein. (A) Table showing peptide coverage of HA-tagged ELMO in 5
independent mass spectrometry experiments compared to 3 untagged ELMO control experiments. Aside from ELMO itself, the most abundant
associated protein detected was Mbc, followed by CG31048. (B) Protein schematic of Spg and related proteins. Spg is the most similar to vertebrate
DOCK3 and DOCK4. The most closely related fly protein is Mbc. SH3 (Src-homology domain-3); DHR-1 (DOCK Homology Region-1); DHR-2 (DOCK
Homology Region-2); PxxP (Proline-rich region). (C) Both tagged and untagged ELMO are expressed under control of the muscle-specific mef2-GAL4
driver. Embryonic lysates are immunoprecipitated with anti-HA and immunoblotted with antisera against Spg (top panel). Inputs show loading of
total ELMO protein (middle panel) and HA-tagged protein (bottom panel).
doi:10.1371/journal.pone.0016120.g001
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the lethality of spg is due to the spg locus, we were able to rescue
this lethality by driving a UAS-spg cDNA with the early nanos-GAL4
driver (n=208). As maternal spg mutants die early and could not
be examined for defects in later developmental processes, we
examined embryos zygotically mutant for spg
242/spg
242 for defects
in nervous system development.
For proper innervation of muscles in development, neurons
send out actin-rich growth cones (outgrowth), bundle and
unbundle when appropriate (fasciculation), and make decisions
to cross the ventral nerve cord (axon guidance). For all
experiments that include analysis of axon outgrowth and guidance,
Fasciclin II (FasII) was utilized to label three tracts of longitudinal
fascicles that run parallel to the nerve cord. A WT embryo labeled
with FasII is shown in Figure 3A. Breaks in the longitudinal
fascicles indicate axon stalling or outgrowth defects, while axons
that cross the ventral midline are misguided. The global neuropile
marker BP102 labels all longitudinal and commissural axons,
resulting in a ladder-like appearance of the axonal projections
(Figure 3F). Consistent with a maternal contribution of Spg
mRNA and protein, embryos homozygous mutant for the spg
242
allele exhibited minor defects in the axonal patterns. Labeling with
FasII revealed infrequent breaks in the outer longitudinal tract,
while occasional thinning of these tracks were observed with
BP102 (Figures 3B, G; Table 1). We could not address whether
protein was reduced in spg
242 animals as the stop codon at AA487
truncates the protein before the region against which the Spg
antibody was produced. Thus, we chose to analyze spg
242 over the
deficiency line Df(3R)3450, which removes the spg locus [53]. In
embryos of the genotype spg
242/Df(3R)3450, we observed a similar
percentage of gaps in the outer longtudinal fascicles to that of
spg
242/ spg
242 (Table 1). Furthermore, the frequency of outgrowth
defects observed in spg
805/Df(3R)3450 and spg
242/ spg
805 alleleic
combinations were consistent (Table 1, Figure S1). To see if we
could observe increased defects via neuronal-specific knockdown of
Spg, we expressed UAS-spg RNAi using the pan-neuronal driver
C155-GAL4. In addition to increased axon outgrowth defects
(Table 1), we observed occasional bifurcated bundles, indicative of
fasisculation or abnormal fusion defects (Figure S1E). The
localization of spg expression in the developing nerve cord and
Spg-ELMO complex based upon mass spectrometry results led us to
examine the role of elmo genetically in development of the CNS. As
predicted based upon the maternal contribution of ELMO mRNA
and protein, embryos homozygous mutant for elmo
19F3exhibited
minor defects in axonal patterning. FasII labeling revealed a nearly
wild-type pattern of all longitudinal fascicles, while occasional
thinning of these tracks and increased length of adjacent segments
were observed with BP102 (Figures 3C, H; Table 1). As described in
Geisbrecht et al., this allele contains a stop codon at amino acid 393
and appears to be null as removal of both the maternal and zygotic
contribution of elmo by germline clone analysis (GLC) resulted in
early embryonic lethality [27]. Consistent with this, FasII staining in
embryos homozygous for the deletion allele elmo
ko [49] appeared
normal (Table 2) and also resulted in early embryonic lethality when
analyzed by GLC analysis. To reduce elmo function, yet allow
animals to survive until the later stages of embryogensis when CNS
development occurs, we used a hypomorphic elmo allele for GLC
analysis [27]. In representative embryos maternally and zygotically
mutant for elmo
PB[c06760], a dramatic increase in axonal patterning
defects were observed. In addition to an increased number of outer
fasciclegaps, we saw aberrant midline crossing oflongitudinalaxons,
and misrouting of outer longitudinal axons (Figures 3D, I; Table 2).
This suggests that elmo functions in CNS development in addition to
its role in myoblast fusion and border cell migration [27,49].
If two genes act in the same pathway, transheterozygosity for
the two genes of interest may result in a phenotype stronger than
the single mutants alone. This type of experiment is complicated in
the case of elmo and spg, which are both contributed maternally. To
Figure 2. Spatial expression of Spg in the developing embryo. (A–F) In situ hybridizations of wild-type embryos showing spg mRNA
expression. (A) Stage 11 embryo shows expression in the nervous system primordia. (B) Expression in the ventral nerve cord and sensory primordia at
stage 13. (C, D) In dorsal views, spg is expressed in the brain and visceral mesoderm (arrowheads) at stage 13 (C) and brain and dorsal vessel at stage
16 (D, arrow). (E, F) At stage 16, expression is high in the ventral nerve cord in both lateral (E) and ventral (F) views. Arrow designates dorsal vessel
expression (E). (G–I) Expression of Spg visualized by immunohistochemical staining. Spg is expressed is the ventral nerve cord in stage 13 (G) and
stage 15 (H) embryos. Low expression is also detectable in the gut mesoderm (H). (I) A ventral view shows expression in the both the ventral nerve
cord and peripheral neurons (arrows). (J-L0) Immunofluorescent confocal micrographs of Spg protein and neuronal markers. (J-J0) In stage 13
embryos, Spg expression overlaps with BP102 in both longitudinal and commissural axons. (K-K0) Spg is not expressed in repo (+) glial cells or ventral
midline glial cells (L-L0). Anterior is left and dorsal is up in A, B, E, G, H. Scale bar=50 mm.
doi:10.1371/journal.pone.0016120.g002
DOCK Family Members in Drosophila CNS Development
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16120examine if loss-of-function phenotypes could be exacerbated by
removalofgenesthatfunctioninthe samepathway,zygoticembryos
of the genotype elmo
19F3/elmo
19F3; spg
242/spg
242 were analyzed.
Compared to elmo/elmo (0.0%; n=133) or spg/spg (10.0%; n=100)
single mutants, a consistent increase in longitudinal axon defects
were observed in the double mutants (37.7%; n=106; Table 2). In
addition,weobservedanincreaseinaxons thatinappropriatelycross
themidline(Table2).ArepresentativeexampleisshowninFigure3E
and quantified inFigure 3K. ByBP102 staining,abnormalities in the
spacing between adjacent segments was also enhanced (Figure 3J).
There are two possibilities to explain this result: (1) the double
mutant is phenotypically stronger than either single mutant as the
residual maternal products are compromised; or (2) the stronger
phenotypes observed in the double mutant combination are a result
of two pathways being affected. The two possibilities are not
mutually exclusive. We favor the first hypothesis as we know Elmo-
Spg are found in a complex based upon our MS and IP results.
Furthermore, we do not observe genetic interactions with other
candidates that may function with elmo.
Figure 3. Embryos with loss of both zygotic elmo and spg exhibit abnormal axonal patterns. Late stage 16 or stage 17 embryos stained
with anti-FasII to reveal subsets of longitudinal axons (A–E) and anti-BP102 to label all CNS axons (F–J). Anterior is up in all panels. (A, F) In WT
embryos, FasII is expressed in 3 longitudinal bundles along each lateral side of the ventral nerve cord and BP102 labels both longitudinal and
commissural axons on either side of the midline. (B, G) Removal of zygotic spg results in minor gaps in the outermost longitudinal fascicles (B,
arrowhead) and a largely normal ladder-like pattern with occasional thinning of the longitudinal axons (G, arrowhead). (C, H) Embryos that lack
zygotic elmo look similar to WT as visualized by anti-FasII (C) and reveal minor thinning of longitudinal axons with anti-BP102 (H, arrowhead). (D, I)
Removal of maternal and zygotic elmo visualized by FasII (D) reveal discontinuous bundles of lateral axon tracts (arrowheads) and aberrant midline
crossing of fascicles (arrow). Misrouted 1D4-positive axons are also seen outside the normal longitudinal pathways (asterisk). (I) Thinner longitudinal
axons (arrowhead) and abnormal commissural patterns are present with BP102 in elmo
m-z- animals (I). (E) Analysis of embryos homozygous for both
zygotic elmo and spg exhibit more severe axonal discontinuities and/or fusion to adjacent fascicles (arrowheads), in addition to inappropriate midline
crossing (arrow). (J) These embryos also exhibit abnormal patterning of longitudinal and commissural axons (compare length of 2 consecutive
segments denoted by line in J to F–I). (K) Graph depicting the percent of hemisegments that exhibit either gaps or missing axons and ectopic fascicle
crossing in either spg or elmo mutants alone or elmo, spg double mutants. All embryos were stained with FasII for scoring (see table 1 for complete
data set). Statistical significance was determined by student T-test.
doi:10.1371/journal.pone.0016120.g003
Table 1. spg alleles exhibit minor axonal outgrowth defects.
Genotype
Outgrowth
Defects
a
Guidance
Defects
b
Segments
Scored (n)
spg
242/spg
242 10 (10.0%) 0 (0.0%) 100
spg
242/Df(3R)3450 14 (14.8%) 2 (2.1%) 94
spg
805/Df(3R)3450 21 (11.7%) 1 (0.0%) 179
spg
242/spg
805 28 (13.8%) 0 (0.0%) 202
c155-GAL4/UAS-spgRNAi 73 (28.0%) 0 (0.0%) 260
Stage 16–17 embryos stained with anti-FasII were scored.
aScored as longitudinal axon tracts missing from either or both sides of nerve
cord/segment.
bNormal fascicle(s) ectopically crossing the midline.
doi:10.1371/journal.pone.0016120.t001
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lacking Spg
Based upon the complementary expression patterns for mbc and
spg in the somatic musculature and developing CNS, respectively,
an attractive notion would be that ELMO binds to and functions
with Mbc and Spg in a tissue-specific manner. To explore this, we
examined phenotypes of single and/or double mutants in both
muscle and nervous system development. Consistent with our above
results that removal of zygotic spg exhibited almost wild-type axonal
patterning, no myoblast fusion defects were observed in zygotic
spg
242/spg
242 mutant embryos (Figure 4A). In addition, we did not
observe unfused myoblasts just under the somatic muscle layer (data
not shown). In contrast to defects observed in the CNS in elmo; spg
double mutants, analysis of the final muscle pattern in these
embryos appeared wild-type (Figure 4B). As previously reported,
loss-of-function mutations in mbc resulted in strong myoblast fusion
defects in the developing embryo [11,26]. In homozygous embryos
mutant for mbc
D11.2, the myoblasts were competent to migrate to the
founder cells where fusion normally takes place, while fusion did not
occur (Figure 4C). To examine if spg may be functioning
redundantly with mbc in myoblast migration, the distribution of
myoblasts was examined in mbc
D11.2, spg
242/mbc
D11.2, spg
242 double
mutants. While the myoblasts fail to fuse as in mbc mutants, they
were still capable of clustering around the founder cells, suggesting
that myoblast migration was not affected (Figure 4D).
Both Spg and Mbc are required for axonal patterning
The experimentsabove indicate Spg is not required in embryonic
muscle development. To further examine if Spg is the only DOCK
family member required for axonal patterning, we examined the
potential contribution of Mbc in the developing nervous system.
Similar to defects already observed in spg mutants, embryos
homozygous mutant for mbc
D11.2 exhibited breaks in the outer
longitudinal fascicles (Figure 5A; Table 2). In addition, we observed
collapse of axons onto the MP1 fascicle tracts (data not shown).This
extends and supports observations by Nolan, et al., where it was
determined that embryos transheterozygous for mbc
1.63/mbc
4.25
exhibited ventral nerve cord defects upon examination with BP102
[32]. Our analysis using BP102 phenocopies their results, where we
observed thinning of the longitudinal axon tracts and abnormal
spacing between segments (Figure 5C). This suggests that low
expression of mbc, possibly undetected in the CNS due to high
expression in the muscle, contributes to nervous system formation.
As Spg and Mbc are the two DOCK family members predicted
to be specific for Rac and mutations in either one exhibit defects in
the nervous system, we sought to examine if embryos mutant for
both mbc and spg resulted in enhanced nervous system defects. We
did not observe a significant increase in broken fascicles or the
collapse of the outer longitudinal tracts in mbc, spg double mutants
over mbc mutants alone (Figure 5B, Table 2). However, we did
observe an increase in midline fascicle crossing in these double
mutants (Figure 5B, arrows, Table 1). There was also an increase in
abnormal positioning of the ventral nerve cord in mbc, spg double
mutants, where 48.2% of mutant embryos (n=56) exhibited
abnormal swerving of the nerve cord seen on the ventral side
(Figure 5B, 5D) or abnormal bends in lateral views (Figure 5F
compared to Figure 5E), which was rare in single mutants of spg
(0.0%; n=23) or mbc mutants (0.8%; n=22). The above data
suggests Mbc may be the primary DOCK family member in tissues
like the muscle, while both Spg and Mbc may function in other
tissues, such as CNS development and border cell migration.
Expression of N-cadherin is sufficient to recruit Spg to the
membrane in S2 cells
Scanning through our list of potential MS candidates, N-
cadherin (Ncad) emerged as a possible upstream receptor to
mediate signaling via DOCK-ELMO complexes, albeit at low
levels. Furthermore, Ncad is expressed in the embryonic fly
Table 2. Genetic interactions between elmo, spg, mbc, and N-cad.
Genotype
Outgrowth
Defects
a
Guidance
Defects
b
% Segments
Abnormal
c
Segments
Scored (n)
% Embryos to severe
to quantitate
y, w 0 (0.0%) 0 (0.0%) 0.0% 101 0.0% (n=15)
elmo
KO/elmo
KO 1 (0.8%) 0 (0.0%) 0.8% 133 0.0% (n=16)
elmo
PBm-z- 35 (44.8%) 5 (6.4%) 72.0% 79 0.0% (n=17)
spg
242/spg
242 10 (10.0%) 0 (0.0%) 10.0% 100 0.0% (n=13)
elmo
KO/elmo
KO; spg
242/spg
242 40 (37.7%)** 13 (12.2%)** 50.0% 106 0.0% (n=21)
mbc
D11.2/mbc
D11.2 23 (34.3%) 3 (4.4%) 38.8% 69 0.0% (n=21)
spg
242,m b c
D11.2/spg
242,m b c
D11.2 97 (39.7%) 23 (9.4%) 49.1% 244 11.3% (n=63)
Ncad1
405/Ncad1
405 24 (23.0%) 3 (2.8%) 25.9% 104 0.0% (n=17)
Ncad
D14/Ncad
D14 81 (35.0%) 7 (3.0%) 38.0% 231 0.0% (n=43)
Ncad
D14/+,s p g
242/spg
242 22 (40.0%)** 0 (0.0%) 40.0% 55 ND
Ncad
D14/Ncad
D14; spg
242/spg
242 97 (46.0%)** 48 (23.0%)** 69.7% 208 7.4% (n=27)
Ncad
D14/Ncad
D14; mbc
D11.2/mbc
D11.2 115 (36.5%) 7 (2.2%) 38.7% 315 6.0% (n=19)
Ncad
D14/Ncad
D14, elmo
19F3/elmo
19F3 133 (56.1%)** 10 (4.2%) 60.3% 237 4.7% (n=63)
Stage 16–17 embryos stained with anti-FasII were scored.
aLongitudinal axon tracts missing from either or both sides of nerve cord/segment.
bNormal fascicle(s) ectopically crossing the midline.
c% segments abnormal includes all defects observed in a and b.
m-z- designates removal of maternal and zygotic contribution.
**indicates p,0.05 using student T-test compared to single mutants alone.
ND=not determined.
doi:10.1371/journal.pone.0016120.t002
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Ncad in regions of cell-cell contact in the nerve cell line PC12
[40,54]. Thus, Ncad seemed a reasonable candidate to examine
it’s involvement with DOCK-ELMO complexes in CNS devel-
opment. To gain insight into a potential Ncad-Spg interaction, we
examined the subcellular distribution of Spg and Ncad protein in
Drosophila S2 cells. RT-PCR results show that spg is endogenously
expressed in S2 cells (data not shown). Furthermore, staining with
anti-Spg antibody reveals a cytoplasmic localization of the protein
(Figure 6A). As S2 cells do not endogenously express Ncad, cells
transfected with full-length Ncad were stained for Ncad and Spg
protein. In transfected cells, Ncad was detected at the membrane
and was capable of aggregating with other Ncad(+) cells
(Figure 6B9), a hallmark of the homotypic cell adhesion properties
of the Cadherin family of proteins [54]. The subcellular
distribution of Spg was cytoplasmic in Ncad(2) cells (Figure 6A,
6A0, 6B, 6B0), but became membrane localized upon expression of
Ncad (Figure 6A9,6 A 0). In Ncad(+) cells that formed clusters, Spg
localization was enriched at the membrane between adjacent cells
(Figure 6B9,6 B 0). To quantify these observations, we acquired
confocal images of S2 cells both with and without Ncad
expression. As shown in Fig. 6, we observed membrane-enriched
Spg in 89.2% of cells (n=102) of Ncad (+) cells compared to
0.04% of S2 cells that do not express Ncad (n=210).
Genetic analysis of Ncad-Spg mutants
Based upon the results that Spg is enriched at the membrane
upon expression of Ncad in S2 cells, we wondered if removal of
Ncad could increase the severity of spg
242/spg
242 axonal pheno-
types. As previously reported for other Ncad alleles, mutants for
Ncad
405/Ncad
405(Ncad) alone show mild CNS defects (Figure 7A;
Table 2) [54]. The Clandinin lab created mutants that remove
both Ncad and the recently characterized N-cadherin2 (Ncad, Ncad2
double mutant, hereafter called Ncad
D14) [55]. Thus, we examined
Ncad
D14mutants to determine if these proteins may function
redundantly in CNS development. It appears the contribution of
Ncad2 is minor or negligible as our results do not show quantifiable
differences between Ncad mutants alone or Ncad
D14/Ncad
D14
double mutants (Table 2). Removal of one copy of Ncad
D14 in a
spg
242/spg
242 homozygous mutant background increased the
occurance of axon outgrowth defects over spg
242 mutants alone
(Table 2). To examine this further, we also quantitated embryos
double mutant for both Ncad
D14 and spg
242. We observed a modest,
although significant increase in axon outgrowth phenotypes over
Ncad
D14 mutants alone (Figure 7C, Table 2). Consistent with this,
Ncad
D14, elmo
19F3 double mutants exhibited a consistent enhance-
ment of axonal breaks (Figure 7D, Table 2), although no increase
in midline guidance errors. However, in both double mutant
combinations, we also observed qualitatively different and/or
stronger phenotypes than that observed in the single mutants
alone. For example, we also observed a greater than additive
increase in ectopic midline crossing in Ncad
D14; spg
242 double
mutants (23.0%) over Ncad
D14 (3.0%) or spg
242 (0.0%) mutants
alone. In Ncad
D14, elmo
19F3 double mutants, the embryos showed
an increase in collapsed outer longitudinal axon tracts onto the
MP1 fascicle (Figure 7D, asterisks), a phenotype not observed in
Ncad
D14 or elmo
19F3 mutants alone. These data taken together
suggest that the maternal load of spg or elmo may be masking
phenotypes until the levels of an upstream component is
compromised. An alternative explanation is that Ncad, Spg or
Elmo may also have functions independent of one another in CNS
development. Although mbc is required for axon outgrowth
(Figure 5A), we did not observe an increase in axonal outgrowth
or guidance defects upon removal of Ncad (Figure 7E), suggesting
that Mbc may function independently.
Discussion
Recent investigations of vertebrate DOCK family proteins
demonstrate that DOCK-ELMO complexes function together to
regulate downstream GTPases, namely Rac. In this study, we
uncover the Drosophila DOCK family member Spg, and find that
mutations in elmo, spg,o rmbc exhibit abnormal axonal patterning
in the embryonic CNS. Ncad is capable of relocating cytosolic Spg
Figure 4. Loss of zygotic spg is not sufficient to reveal myoblast fusion defects. (A–D) Lateral views of stage 16 embryos stained with anti-
MHC to visualize the final muscle pattern. (A, B) A wild-type muscle pattern is seen in mutants that lack zygotic spg (A) and both zygotic elmo and spg
(B). (C, D) Myoblasts fail to fuse but cluster around founder cells (arrows) in mbc mutants (C) and spg, mbc double mutants (D). Scale bar=10 mm.
doi:10.1371/journal.pone.0016120.g004
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mutations in Ncad dominantly enhance the axonal outgrowth
phenotypes of spg mutants and that Ncad; spg and Ncad, elmo double
mutants have more severe CNS phenotypes. Taken together, these
data indicate (1) that Ncad, Spg, and Elmo may function together
during axonal outgrowth, (2) that the severe double mutant
phenotypes reflect a decrease in the function of maternally loaded
components that were masked in single mutants, and/or (3) the
double mutant defects represent a disruption of multiple signaling
pathways.
Identification and characterization of Spg, a DOCK family
member
We identified peptides corresponding to the uncharacterized
protein CG31048 in an in vivo mass spectrometry approach to
identify ELMO-binding partners. The CG31048 locus, which
encodes for Sponge, is a member of the growing family of
Drosophila DOCK family proteins. This report is the second
identification of a DOCK family member in flies since the role of
Mbc was uncovered in 1997 [26]. The 11 vertebrate DOCK
proteins identified thus far can be divided into subgroups based
upon primary sequence analysis and GTPase target specificity for
either Rac or Cdc42 [5,10,50]. In the first group, the DOCK-A
family consists of DOCK180, DOCK2, and DOCK 5, while the
DOCK-B subfamily is comprised of DOCK3 and DOCK4. In
flies, this redundancy is simplified with the 2 DOCK family
members, Mbc and Spg, whom are members of the DOCK-A and
DOCK-B groups, respectively. All of the above family members
contain an N-terminal SH3 domain, 2 internal DHR (CZH)
domains and a variable C-terminal proline-rich region. Further-
more, they function as unconventional guanine nucleotide
exchange factors (GEFs) for the GTPase Rac. Members of the
DOCK-C (DOCK 6, DOCK7, DOCK8) subfamily and DOCK-
D (DOCK9, DOCK10, DOCK11) subfamily bind to the GTPase
Cdc42. The 2 orthologous Drosophila proteins, CG42533/Dm ziz
(DOCK-C) and CG11376/Dm zir (DOCK-D) have not yet been
characterized in flies.
Alleles of spg were originally identified in a maternal effect
screen and later characterized for their role in actin-dependent
events in early Drosophila embryogenesis [47,48]. Our mRNA and
protein expression analysis suggested Spg may be required after
cellularization due to strong expression in the visceral mesoderm,
dorsal vessel, and developing ventral nerve cord. As removal of the
maternal contribution of spg null alleles results in early embryonic
lethality, the role for spg in later developmental processes had not
been examined. However, the identification of Spg as an ELMO-
interacting protein gave us insight into how to examine the role of
Spg in late embryogenesis using double mutant analysis. While
zygotic single mutants of spg and elmo appeared essentially wild-
type, removal of both the zygotic contribution of both spg and elmo
resulted in axonal patterning defects. We favor the hypothesis that
the maternal contribution of both Elmo and Spg mask any
embryonic phenotypes until the levels of both proteins are
compromised. Alternatively, though not mutually exclusive, is
the possibility that Elmo and Spg function in parallel pathways
and our observed phenotypes are a result of these additive effects.
As mentioned above, removal of either spg or elmo maternal
contribution results in early embryonic lethality [27]. As spg has
shown to be required for early actin cap and metaphase furrow
formation, it is fair to hypothesize that that these two genes may
function in concert in early embryo development, where Mbc is
not required.
Downstream GTPase of the DOCK-ELMO complexes
Vertebrate DOCK 4 was originally identified as a CDM family
member capable of activating the small GTPase Rap1 in GTPase
pull-down assays [56]. Functionally, a deletion of endogenous
DOCK4 in osteosarcoma cells was shown to rescue the formation
of adherens junctions and could be suppressed by co-expression of
dominant-negative Rap1 [56]. Recent studies have demonstrated
that DOCK 4 is also capable of activating the GTPase Rac1
[45,51,57]. This data suggests that GTPase activation of either
Rac and/or Rap1 by the Spg-ELMO complex is context and/or
tissue-dependent. Our current model for DOCK-ELMO function
in embryogenesis is shown in Figure 8. Only the Mbc-ELMO
complex functions in the developing musculature to activate the
GTPase Rac. While it is clear that regulation of the actin
cytoskeleton is downstream of the Mbc-ELMORRac signaling
pathway, the upstream receptors that mediate this signaling are
unknown. Our data suggests that both Mbc and Spg function in
Figure 5. CNS defects are enhanced in embryos missing both
spg and mbc. Late stage 16 or stage 17 embryos stained with anti-FasII
(A, B, E, F) and anti-BP102 to label all CNS axons (C, D). (A, C) mbc
mutants have more discontinuities in the outermost fascicles (A,
arrowhead) and thinner longitudinal axons (C, arrowheads). (B, D)
Mutants missing both spg and mbc have an increase in (B) missing and
collapsed longitudinal fascicles (arrowhead) and abnormal crossovers
(arrows). BP102 staining (D) shows a severe thinning of axons
(arrowhead) and abnormal spacing between segments (compare length
of 2 consecutive segments denoted by line in panels C and D). (E, F)
Lateral views of stage 16 embryos stained with anti-FasII show
abnormal positioning of the ventral nerve cord in spg, mbc mutants
(F, arrow) compared to mbc mutants alone (E). Anterior is up in panels
A–D. Anterior is left and dorsal is up in panels E, F.
doi:10.1371/journal.pone.0016120.g005
DOCK Family Members in Drosophila CNS Development
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16120the Drosophila developing nervous system. All literature thus far
supports a model whereby the Mbc-ELMO complex activates
Rac. Alternatively, the Spg-ELMO complex may regulate Rac
and/or Rap1 activity. If both the Mbc-ELMO and Spg-ELMO
protein complexes function upstream of Rac, they may be acting
redundantly to regulate Rac-dependent actin cytoskeletal changes.
Alternatively, the downstream effector functions of Rac activity
may lead to changes in cell-cell adhesion or may be mediated
through the GTPase Rap1. We hypothesize that differences in the
C-terminal proline-rich regions of Mbc and Spg may be
responsible for their differential activities. In myoblast fusion, the
proline-rich region of Mbc is not required [11]. However, Spg and
vertebrate DOCK3/4 contain additional proline-rich sites not
present in Mbc/DOCK180. Further experiments will be necessary
to define the cellular and molecular mechanisms necessary to carry
out DOCK-ELMO functions in the developing CNS.
Regulation of GEF activity
ELMO expression is ubiquitous throughout fly development,
while Mbc and Spg expression is predominant in the muscle and
Figure 6. Expression of N-cadherin is sufficient to recruit Spg to the membrane. (A-Bii) Confocal micrographs of S2 cells transfected with
Ncad and stained for Ncad (green) to detect transfected cells and endogenous Spg (red). (A-Aii) In a singly transfected cell, Spg is recruited to the
membrane (closed arrowhead) compared to untransfected cells where Spg is cytoplasmic (open arrowhead). (B-Bii) Homotypic cell adhesion between
two Ncad-expressing S2 cells also results in apparent membrane Spg staining (closed arrowhead), most notably at sites of cell-cell contact between
adjacent cells (arrow). (C) Quantification of Spg subcellular localization in cells either transfected with or without Ncad. The percentage of S2 cells
were scored for either membrane or cytoplasmic Spg localization. Scale bar=5 mm.
doi:10.1371/journal.pone.0016120.g006
Figure 7. Genetic interactions between Ncadherin, elmo, spg, and mbc. (A–E) Anti-FasII staining to visualize longitudinal axons. (A, B) Removal
of zygotic Ncad (A) or both N-cadherin genes (Ncad
D14) (B) exhibit mild axonal break defects (arrowheads). (C) A significant increase in both fascicle
axonal breaks (arrowhead) and ectopic midline crossing (arrows) are observed in Ncad
D14; spg double mutants. (D) Removal of both Ncad
D14 and elmo
function results in an increase in axonal patterning defects, including a collapse of the outer fascicle tract onto the MP1 fascicle (asterisk and arrow)
and an increase in axonal gaps (arrowhead). (E) Ncad
D14; mbc double mutants exhibit many breaks in the outer longitudinal fascicles (arrowhead),
similar to that of Ncad
D14 or mbc alone. (F) Graph showing the percent of hemisegments that exhibit missing axons or ectopic fascicle crossing in
Ncad
D14, spg,o rmbc single and double mutants. A statistically significant difference (using student t-test) is observed in Ncad
D14; spg double mutants
versus the Ncad
D14 or spg single mutants alone. However, analysis of double mutants of Ncad
D14; mbc do not show a significant increase in axonal
defects over the single mutants alone.
doi:10.1371/journal.pone.0016120.g007
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expression patterns of Mbc and Spg, we originally hypothesized
that complementary expression patterns may be one mechanism
for the tissue-specific regulation of Rac activation through the
DOCK-ELMO complexes. However, our results indicate that the
role of Mbc-ELMO and Spg-ELMO is more complicated. While
the Mbc-ELMO complex seems to be the primary GEF complex
for Rac activation in the musculature, both the Mbc-ELMO and
Spg-ELMO complexes may both be necessary to correctly pattern
axons in the developing central nervous system. In support of the
idea that both complexes are required in certain developmental
situations, the Rorth lab found that both Spg and Mbc are
required in border cell migration [49]. Removal of both Spg and
Mbc function in the border cells phenocopies loss of ELMO,
suggesting that these 2 genes function in concert with ELMO to
guide migration. Further experiments are required to determine if
the observed CNS defects in spg and mbc mutants are autonomous
in the nervous system. Alternatively, axonal patterning defects
observed in mbc mutants may be a secondary consequence due to a
requirement for Mbc in the musculature.
In the musculature, the only known GEF shown to be required
for Rac activation is the Mbc-ELMO complex. However, in the
developing nervous system, in addition to the unconventional
DOCK-ELMO complexes, the conventional GEFs Trio and Sos
are required [9,58,59,60,61]. It is not clear how these multiple
GEFs are regulated throughout CNS development. Possible
mechanisms include the: (1) regulation of GEF expression either
in subsets of specific neurons or precise subcellular localization
within the same neuron; (2) unique physical associations between
GEFs and receptors specific for distinct steps in axonal patterning;
and (3) regulation of GEF activity via post-translational modifi-
cations including phosphorylation or ubiquitination. While these
ideas have not been examined in detail for all known GEFs, what
is known is discussed below.
First, it is possible mechanisms exist within the cell or tissue to
compartmentalize GEF function as the spatial expression patterns
of all GEFs in the developing ventral nerve cord seems to be fairly
broad. Mbc is expressed at low or undetectable levels with
reagents currently available, while Spg is expressed in all
commissural and longitudinal axons, but not glial cells. Likewise,
Sos protein is broadly expressed in many cell types around stage
12 and becomes enriched in CNS axons [9]. While Trio is
expressed in axons that run on longitudinal tracts and those that
cross the midline, enrichment of this protein is evident in the
longitudinal fascicles [58]. Trio is largely localized near the
membrane [62], while cytoplasmic Spg and Sos can be recruited
to the membrane by their association with N-cadherin and Robo,
respectively [9]. It is not yet clear if membrane recruitment is
sufficient to promote Rac activation, or if conserved mechanisms
exist to activate GEFs where their activity may be needed. For
example, by binding to RhoG, ELMO can target DOCK180 to
the membrane [17]. In addition, ELMO binding to DOCK180
relieves a steric inhibition by exposing the DHR-2 domain of
DOCK180 that binds Rac [16]. This remains to be shown for
other DOCK family members.
Next, it is possible that each distinct step of neuronal
pathfinding requires a unique set of proteins that allow upstream
receptors to signal to downstream proteins for a specific biological
output. For example, Trio cooperates with the Abelson tyrosine
kinase (Abl) to promote Rac-dependent actin cytoskeletal dynam-
ics in Frazzled-mediated commissure formation [8]. In the
separate process of longitudinal fascicle formation, a trimeric
complex of Robo-DOCK-Sos activates Rac to promote axon
repulsion [9]. Separately, N-cadherin is suggested to be required
for fasciculation and directional growth cone migration [54].
Thus, the Ncad-DOCK-ELMO complex may be responsible for
this latter aspect of axonal pathfinding, while other steps may be
mediated by individual receptor-GEF complexes. However,
additional evidence suggests this regulation may be more complex.
Preliminary data from our laboratory demonstrates that Ncad may
genetically interact with other Rac GEFs to affect earlier CNS
development Ncad mutants cannot be rescued by expression of
Figure 8. Model of CDM-Elmo pathway. In the muscle, Mbc is the sole CDM family member that functions with Elmo to mediate cytoskeletal
modifications through the GTPase Rac (left panel). In a neuronal cell (right panel), both Mbc and Spg contribute to nervous system formation. In this
model, the Mbc-Elmo complex is downstream of yet unidentified proteins and presumably signals through Rac. In contrast, our data suggests Spg-
Elmo may function downstream of Ncad. The target of the Spg-Elmo complex, whether it be Rac and/or Rap is unclear.
doi:10.1371/journal.pone.0016120.g008
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unpublished data). DOCK180 binds the vertebrate receptor
Deleted in Colorectal Cancer (DCC) (similar to the Netrin
receptor Fra in flies) [63]. In addition, inhibition of DOCK180
activity decreased the activation of Rac1 by Netrin [37]. Another
study suggests that Robo is required for multiple, parallel pathways
in axon guidance and activated Robo function inactivates N-
cadherin-mediated adhesion [63]. Current models suggest acti-
vated Robo binds to Abl and N-cadherin, thus providing a
mechanism to weaken adhesive interactions during fasciculation to
allow for mediolateral positioning of axons along the ventral nerve
cord. The association of either Mbc or Spg proteins in the Netrin
signaling pathway has not been examined. So far, we have not
observed significant differences in genetic combinations that
remove either robo or slit in elmo mutants (Lui, Z. and Geisbrecht,
E.; unpublished data). Furthermore, no significant increases in
midline guidance errors were observed in Ncad, elmo mutants,
suggesting that Ncad and Spg may function in this process
independent of ELMO function. It is clear that additional analysis
of Robo and N-Cadherin dynamics are needed in the well-
established CNS fly model to determine their in vivo relevance.
Finally, the physical interactions of GEF proteins with specific
membrane receptors may allow the GEFs to be in a unique
subcellular localization for post-translational modifications that
regulate activity. As mentioned above, DOCK180 is capable of
binding and activating Rac when sterically relieved upon ELMO
binding [16]. In addition, the presence of ELMO1 inhibits the
ubiquitination of DOCK180, thus stabilizing the amount of GEF
available to activate Rac [64]. Finally, although the significance is
unclear, DOCK180 is phosphorylated upon Integrin binding to
the extracellular matrix [65]. Trio has also been shown to be
tyrosine phosphorylated upon co-expression with Abl [8],
suggesting this may be a common mechanism for GEF regulation.
ELMO is also phosphorylated on tyrosine residues [66], providing
another level of GEF regulation. Further experimentation must be
done to determine whether these modifications of GEFs also lead
to regulation of Rac activity.
Materials and Methods
Genetics
Fly stocks were raised on standard cornmeal medium at 25uC
unless otherwise indicated. Oregon R was used as the wild-type
strain. The following alleles/fly stocks were used: elmo
19F3,
P{ry[+7.2]=neoFRT}40A (Geisbrecht, et al, 2008); elmo
PB[c06760],
P{ry[+7.2]=neoFRT}40A (Geisbrecht, et al, 2008); elmo
KO (Bianco,
et al, 2007); spg
242 and spg
805 (kindly provided by Eyal Schejter);
mbc
D11.2 (Erickson, et al, 1997); Ncad1
omb405 (Yonekura, et al, 2007);
Ncad
D14 (Prakash, et al., 2005). elmo
PB.mat mutants were created as
previously described (Geisbrecht, et al, 2008). The following stocks
were generated by standard meiotic recombination and isolated on
the basis of their failure to complement other alleles and/or
sequencing to verify the molecular lesion: Ncad
D14; elmo
19F3; spg
242,
mbc
D11.2. Additional stocks were generated by standard fly crosses:
elmo
KO; spg
242 and Ncad
D14; mbc
D11.2. C155-GAL4 and nanos-GAL4
were obtained from the Bloomington Stock Center and UAS-
spgRNAi flies were obtained from the Vienna Drosophila RNAi
Center (VDRC).
In situ hybridization and immunostaining
Embryos were collected on agar-apple juice plates and aged at
25uC. For in situ analysis, multiple internal sequences encoding spg
were transcribed with Sp6 using the DIG mRNA labeling kit
(Roche) and hybridized as described [27]. For immunohistochem-
istry, embryos were fixed and stained as described [27]. The
musculature was visualized using anti-MHC (1:500). The CNS
was labeled using mAb 1D4 (1:100, Developmental Studies
Hybridoma Bank, University of Iowa) and mAb BP102 (1:20,
Developmental Studies Hybridoma Bank, University of Iowa).
Secondary antibody was goat anti-mouse-HRP (1:200, Jackson).
Fluorescent immunostaining was performed as previously de-
scribed in Geisbrecht, et al [27]. Primary antibodies used were
anti-Repo (1:50, Developmental Studies Hybridoma Bank,
University of Iowa) and anti-Slit (1:50, Developmental Studies
Hybridoma Bank, University of Iowa) and detected fluorescently
using Alexa Fluor 488 goat anti-mouse IgG at 1:400 (Molecular
Probes, Carlsbad, CA). Tyramide staining was used to enhance
Spg signal for immunofluorescent stainings (Vector Labs,
Burlingame, CA).
Mass spectrometry identification and
immunoprecipiations
Mass spectrometry experiments were described previously [27].
For immunoprecipitations, ELMO-HA-tagged and untagged
transgenic flies were crossed to mef2-GAL4 females and 6–18h
embryos were collected on agar-apple juice plates at 25uC.
Embryos were dechorionated and homogenized in lysis buffer
[60mM Tris (pH 7.5), 80mM NaCl, 6mM EDTA (pH 8.0), 2%
Triton X-100, 1mM Na3VO4, 5mM 1-Naphthyl phosphate
potassium salt, 2mM PMSF, 2 ug/ml Leupeptin, 2 ug/ml
Pepstatin]. The NaCl concentration was increased to 300mM
and resulting lysate mixed with anti-HA resin overnight at 4uC.
The resin was washed 3 times with wash buffer plus protease
inhibitors, boiled in 66 sample buffer and submitted to SDS-
PAGE and subsequent Western blotting. The following primary
antibodies were used for immunoblotting: anti-Spg (1:1000, this
paper), anti-ELMO (1:1000) and anti-HA-HRP (1:2000, Roche).
After incubation with goat anti-guinea pig-HRP (Jackson), proteins
were visualized with ECL Plus (Amersham).
Constructs and Spg antibody production
A full length spg cDNA sequence was generated by analyzing
multiple, overlapping fragments generated by RT-PCR using S2
cells and 0–6 h embryos as a reference source. A full length cDNA
was generated by Epoch Biolabs and cloned into pUAST.
Transgenic flies were produced by Genetic Services, Inc. using
standard techniques. By standard RT-PCR techniques, gene-
specific primers were used to amplify the region of spg
corresponding to AA 1669–2023. The forward and reverse
primers were engineered to contain SalI and NotI restriction
sites, respectively. This cDNA fragment was cloned into the
pT7MHT expression vector and soluble protein was purified as
described [67]. This soluble protein was sent to Pocono Rabbit
Farm and Laboratory Inc. for injection into guinea pigs. The
resulting antisera was used at 1:500.
S2 cell transfections
Transient calcium phosphate transfections of pRmHA3_N-
cadherin were carried out with 1.2610
6 cells/ml and 7–15 ug
DNA as needed. Cells were induced 24 hours after transfection
with 0.7 mM CuSO4. After 48 hrs, cells were resuspended at a
concentration of 1.2610
6 cells/ml in 2 mls of BBS buffer (10mM
HEPES, 55 mM NaCl, 40mM KCl, 15 mM MgSO4,2 0m M
glucose, 50 mM sucrose, and 10 mM CaCl2). The cells were
agitated in a 35 mm dish at 100 rpm for 1 hr. The cells were
plated on poly-L-lysine coated coverslips and fixed for 10 minutes
in 4% PFA in Ca
2+ and Mg
2+-free (CMF) C & GBS (55 mM
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50 mM sucrose)+1 mM CaCl2. Standard immunofluorescent
protocols were followed using rat anti-Ncad (1:20, Developmental
Studies Hybridoma Bank, University of Iowa) and gp anti-Spg
(1:500). Secondary antibodies used were Fluor 488 goat anti-rat
IgG and Fluor 546 goat anti-guinea pig at 1:400 (Molecular
Probes, Carlsbad, CA).
Supporting Information
Figure S1 Loss of Spg results in mild CNS defects. (A–E)
Stage 16 embryos stained with FasII. (A, B) Both spg
242 (A) and spg
805
(B) over a deficiency that removes the spg locus result in mild gaps in
the outer longitudinal fascicles (arrowheads). (C) The same phenotype
are observed in animals trans-heterozygous for spg
242 and spg
805.( D ,
E) Knockdown of Spg by RNAi resulted in similar axonal outgrowth
phenotypes (D) and bifurcated axons (asterisk in E).
(EPS)
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